Health is both outcome of development and input to growth. Disease burden (malaria, tuberculosis, diarrhea) reduces productivity, increases health spending, and reduces savings. Malaria-endemic regions have lower incomes; a 1% increase in life expectancy correlates with 0.3–0.4% long-run growth. Health improvements (vaccination, bed nets, antibiotics) have high returns but access remains limited in poorest countries.
From your study of human capital, you know that a worker's productivity depends not just on education and skills but also on their physical capacity to work. Health is the most fundamental component of human capital — a worker who is frequently ill, physically weakened by chronic infection, or cognitively impaired by childhood malnutrition simply cannot produce at the same level as a healthy one. This creates a bidirectional relationship between health and economic development: wealthier countries can afford better healthcare, but healthier populations are also more productive, meaning health is simultaneously a consequence and a cause of economic growth.
The productivity channel operates at every stage of life. In utero and early childhood, malnutrition and disease impair brain development, reducing cognitive ability and future earnings permanently. Studies of the 1918 influenza pandemic and seasonal famines show that cohorts exposed to health shocks in utero earned significantly less as adults decades later. In working years, diseases like malaria cause periodic incapacitation — a single malaria episode can mean a week of lost work, and in endemic areas, adults may suffer multiple episodes per year. HIV/AIDS devastated the most productive age cohort (20–45) across sub-Saharan Africa, reducing labor supply, destroying household savings through medical costs, and creating millions of orphans who lost both caregivers and educational support.
The economic case for health interventions is striking because many are extraordinarily cost-effective. Insecticide-treated bed nets cost roughly $2–3 each and reduce malaria incidence by 50% or more. Childhood vaccinations cost pennies per dose and prevent diseases that would otherwise kill or disable. Oral rehydration therapy for diarrheal disease costs almost nothing and saves millions of lives annually. The returns to these investments — measured in productivity gains, reduced healthcare spending, and lives saved — dwarf their costs by orders of magnitude. Yet uptake remains low in the poorest regions due to distribution failures, lack of information, and behavioral barriers like present bias in household optimization.
Health also affects development through its impact on savings and demographic behavior. When life expectancy is low and child mortality is high, households rationally respond by having more children (as insurance against child death) and saving less (because the expected period of retirement is short). As health improves and mortality falls, a demographic transition begins: families have fewer children and invest more in each one, and adults save more for a longer expected lifespan. This transition creates a temporary "demographic dividend" — a bulge of working-age adults relative to dependents — that can accelerate growth if the economy generates enough jobs. East Asia's rapid development coincided with exactly this pattern, while sub-Saharan Africa, where the health and demographic transitions have been slower, has yet to fully realize this dividend. The implication for policy is that health investments are not charity — they are among the highest-return investments available in poor countries, with effects that compound across generations.